Clinical Trial Update: Phase Ⅱ Trial of Camrelizumab in Patients Without Distant Metastasis Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial of camrelizumab in patients with nasopharyngeal carcinoma without distant metastasis is being conducted; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Disease-free Survival Rate | Phase 2 | Status: UNKNOWN